Mirna Chehade
Pediatric Gastroenterology · New York, NYNPI 1447229190
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $158,214 of the $216,962 with a category attached, or 72.9%. 11 manufacturers reported payments, led by Regeneron at 41.2% of the total. 2025 is the largest year on record at $63,421, 6.9 times the $9,218 reported in 2019. Among pediatric gastroenterology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 230 payments — averaging $943.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron$89K
- Sanofi$64K
- E.r. Squibb & Sons, L.L.C.$13K
- AstraZeneca$13K
- Takeda Pharmaceuticals U.S.A., Inc.$12K
- Regeneron Healthcare Solutions, Inc.$12K
- plus $13K from 5 others
Across 350 payments — averaging $3010.12 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$854K
- Shire North American Group Inc$81K
- Takeda Pharmaceuticals U.S.A., Inc.$58K
- AstraZeneca$35K
- Bristol Myers Squibb$24K
- Sanofi$2K
What the payments were for
- Consulting fees$158,21473%
- Speaking & faculty fees$4,2502%
- Travel & lodging$48,82923%
- Food & beverage$2,7031%
- Education$2,9671%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron | 143 | $89,327 |
| Sanofi | 19 | $64,347 |
| E.r. Squibb & Sons, L.L.C. | 8 | $12,917 |
| AstraZeneca | 16 | $12,637 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $12,295 |
| Regeneron Healthcare Solutions, Inc. | 13 | $12,097 |
| Shire North American Group Inc | 5 | $4,907 |
| Bristol Myers Squibb | 10 | $4,124 |
| Adare Pharmaceuticals, Inc. | 8 | $2,894 |
| Astrazeneca UK Limited | 1 | $1,167 |
| Sanofi-aventis U.S. LLC | 1 | $250 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$216,962 in reported general payments places this provider in the 95th percentile of 143 pediatric gastroenterology providers in New York.
Other pediatric gastroenterology in New York
- Sivan KinbergNew York$261K
- Michael DolingerNew York$191K
- Thomas WallachNew York$160K
- Neal LeleikoNew York$157K
- John BucuvalasNew York$20K
- Julie KhlevnerNew York$15K
- Joanne LaiNew York$10K
- Jaime ChuNew York$4K
- Elizabeth SpencerNew York$3K
- Robbyn SockolowNew York$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.